Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-24-hour Sleep-wake Disorder Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Prescription Drugs
1.2.3 OTC
1.3 Market by Application
1.3.1 Global Non-24-hour Sleep-wake Disorder Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Non-24-hour Sleep-wake Disorder Treatment Market Perspective (2018-2029)
2.2 Non-24-hour Sleep-wake Disorder Treatment Growth Trends by Region
2.2.1 Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Non-24-hour Sleep-wake Disorder Treatment Historic Market Size by Region (2018-2023)
2.2.3 Non-24-hour Sleep-wake Disorder Treatment Forecasted Market Size by Region (2024-2029)
2.3 Non-24-hour Sleep-wake Disorder Treatment Market Dynamics
2.3.1 Non-24-hour Sleep-wake Disorder Treatment Industry Trends
2.3.2 Non-24-hour Sleep-wake Disorder Treatment Market Drivers
2.3.3 Non-24-hour Sleep-wake Disorder Treatment Market Challenges
2.3.4 Non-24-hour Sleep-wake Disorder Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non-24-hour Sleep-wake Disorder Treatment Players by Revenue
3.1.1 Global Top Non-24-hour Sleep-wake Disorder Treatment Players by Revenue (2018-2023)
3.1.2 Global Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Non-24-hour Sleep-wake Disorder Treatment Revenue
3.4 Global Non-24-hour Sleep-wake Disorder Treatment Market Concentration Ratio
3.4.1 Global Non-24-hour Sleep-wake Disorder Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-24-hour Sleep-wake Disorder Treatment Revenue in 2022
3.5 Non-24-hour Sleep-wake Disorder Treatment Key Players Head office and Area Served
3.6 Key Players Non-24-hour Sleep-wake Disorder Treatment Product Solution and Service
3.7 Date of Enter into Non-24-hour Sleep-wake Disorder Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Non-24-hour Sleep-wake Disorder Treatment Breakdown Data by Type
4.1 Global Non-24-hour Sleep-wake Disorder Treatment Historic Market Size by Type (2018-2023)
4.2 Global Non-24-hour Sleep-wake Disorder Treatment Forecasted Market Size by Type (2024-2029)
5 Non-24-hour Sleep-wake Disorder Treatment Breakdown Data by Application
5.1 Global Non-24-hour Sleep-wake Disorder Treatment Historic Market Size by Application (2018-2023)
5.2 Global Non-24-hour Sleep-wake Disorder Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Non-24-hour Sleep-wake Disorder Treatment Market Size (2018-2029)
6.2 North America Non-24-hour Sleep-wake Disorder Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2018-2023)
6.4 North America Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Non-24-hour Sleep-wake Disorder Treatment Market Size (2018-2029)
7.2 Europe Non-24-hour Sleep-wake Disorder Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2018-2023)
7.4 Europe Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size (2018-2029)
8.2 Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Non-24-hour Sleep-wake Disorder Treatment Market Size (2018-2029)
9.2 Latin America Non-24-hour Sleep-wake Disorder Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2018-2023)
9.4 Latin America Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size (2018-2029)
10.2 Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Teva
11.1.1 Teva Company Detail
11.1.2 Teva Business Overview
11.1.3 Teva Non-24-hour Sleep-wake Disorder Treatment Introduction
11.1.4 Teva Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)
11.1.5 Teva Recent Development
11.2 Mylan
11.2.1 Mylan Company Detail
11.2.2 Mylan Business Overview
11.2.3 Mylan Non-24-hour Sleep-wake Disorder Treatment Introduction
11.2.4 Mylan Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)
11.2.5 Mylan Recent Development
11.3 Nature’s Bounty
11.3.1 Nature’s Bounty Company Detail
11.3.2 Nature’s Bounty Business Overview
11.3.3 Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Introduction
11.3.4 Nature’s Bounty Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)
11.3.5 Nature’s Bounty Recent Development
11.4 Otsuka Pharma (Pharmavite)
11.4.1 Otsuka Pharma (Pharmavite) Company Detail
11.4.2 Otsuka Pharma (Pharmavite) Business Overview
11.4.3 Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Introduction
11.4.4 Otsuka Pharma (Pharmavite) Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)
11.4.5 Otsuka Pharma (Pharmavite) Recent Development
11.5 Boiron
11.5.1 Boiron Company Detail
11.5.2 Boiron Business Overview
11.5.3 Boiron Non-24-hour Sleep-wake Disorder Treatment Introduction
11.5.4 Boiron Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)
11.5.5 Boiron Recent Development
11.6 Miers Laboratories
11.6.1 Miers Laboratories Company Detail
11.6.2 Miers Laboratories Business Overview
11.6.3 Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Introduction
11.6.4 Miers Laboratories Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)
11.6.5 Miers Laboratories Recent Development
11.7 Genexa
11.7.1 Genexa Company Detail
11.7.2 Genexa Business Overview
11.7.3 Genexa Non-24-hour Sleep-wake Disorder Treatment Introduction
11.7.4 Genexa Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)
11.7.5 Genexa Recent Development
11.8 Homeocan
11.8.1 Homeocan Company Detail
11.8.2 Homeocan Business Overview
11.8.3 Homeocan Non-24-hour Sleep-wake Disorder Treatment Introduction
11.8.4 Homeocan Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)
11.8.5 Homeocan Recent Development
11.9 Clinigen Group
11.9.1 Clinigen Group Company Detail
11.9.2 Clinigen Group Business Overview
11.9.3 Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Introduction
11.9.4 Clinigen Group Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)
11.9.5 Clinigen Group Recent Development
11.10 Vanda Pharma
11.10.1 Vanda Pharma Company Detail
11.10.2 Vanda Pharma Business Overview
11.10.3 Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Introduction
11.10.4 Vanda Pharma Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)
11.10.5 Vanda Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details